Business Standard

Fortis Healthcare: Correction a good entry point

Steady growth and value unlocking potential are keeping analysts positive on the company

graph
Premium

graph

Ujjval Jauhari
The Fortis Healthcare stock has fallen about 30 per cent from its all-time high of Rs 230.90 seen in early May as investor sentiment weakened with the promoters’ plan to sell a stake in the company fizzling out. While the news flow around the promoter’s financial services company, Religare Enterprises, may also be weighing on sentiments, analysts say since Fortis Healthcare and Religare are two separate entities, with nil holding in each other, they are not worried.

Analysts say part of the correction is linked to uncertainty over the promoters’ stake sale plan in Fortis as Daiichi Sankyo keeps exploring legal

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 13 2017 | 12:27 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com